Pressure BioSciences, Inc.
OTC:PBIO
0.5 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.978 | 1.729 | 2.002 | 1.221 | 1.81 | 2.458 | 2.24 | 1.976 | 1.798 | 1.375 | 1.503 | 1.238 | 0.988 | 1.34 | 1.245 | 0.852 | 0.646 | 0.21 | 0.106 | 0.413 | 23.296 | 22.765 | 21.826 | 19.47 | 29.3 | 26.1 | 22.3 | 15.5 |
| Cost of Revenue
| 1.178 | 2.014 | 0.942 | 0.583 | 1.197 | 1.28 | 1.273 | 0.834 | 0.609 | 0.652 | 0.568 | 0.416 | 0.343 | 0.377 | 0.402 | 0.401 | 0.209 | 0.165 | 0.177 | 0.572 | 14.865 | 14.263 | 13.121 | 11.242 | 16.9 | 14.8 | 12.1 | 8.6 |
| Gross Profit
| 0.8 | -0.285 | 1.06 | 0.638 | 0.613 | 1.178 | 0.967 | 1.142 | 1.189 | 0.722 | 0.935 | 0.822 | 0.645 | 0.964 | 0.843 | 0.451 | 0.437 | 0.045 | -0.072 | -0.16 | 8.431 | 8.502 | 8.705 | 8.228 | 12.4 | 11.3 | 10.2 | 6.9 |
| Gross Profit Ratio
| 0.404 | -0.165 | 0.529 | 0.522 | 0.339 | 0.479 | 0.432 | 0.578 | 0.661 | 0.525 | 0.622 | 0.664 | 0.653 | 0.719 | 0.677 | 0.529 | 0.676 | 0.214 | -0.681 | -0.387 | 0.362 | 0.373 | 0.399 | 0.423 | 0.423 | 0.433 | 0.457 | 0.445 |
| Reseach & Development Expenses
| 1.367 | 0.97 | 1.102 | 1.143 | 1.157 | 1.208 | 0.989 | 1.183 | 1.105 | 0.953 | 1.035 | 0.966 | 0.969 | 1.233 | 1.175 | 1.811 | 2.023 | 1.43 | 0.499 | 0.42 | 1.816 | 2.611 | 2.303 | 2.444 | 3.3 | 2.5 | 1.3 | 0 |
| General & Administrative Expenses
| 8.205 | 3.243 | 3.819 | 3.43 | 4.581 | 3.437 | 3.416 | 2.823 | 2.903 | 2.387 | 2.475 | 2.605 | 2.034 | 1.925 | 1.809 | 1.92 | 2.175 | 0 | 0 | 0 | 4,345.643 | 4,108.734 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.731 | 0.401 | 0.325 | 0.65 | 0.681 | 1.01 | 1.209 | 0.872 | 0.746 | 0.721 | 0.752 | 0.715 | 0.931 | 1.205 | 1.055 | 1.687 | 1.387 | 0 | 0 | 0 | 3,282.538 | 3,286.183 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.936 | 3.644 | 4.144 | 4.08 | 5.261 | 4.447 | 4.626 | 3.695 | 3.649 | 3.108 | 3.227 | 3.32 | 2.966 | 3.13 | 2.864 | 3.607 | 3.561 | 2.673 | 1.849 | 1.813 | 7.628 | 7.395 | 6.893 | 7.579 | 8.4 | 8.2 | 6.6 | 5.4 |
| Other Expenses
| 0 | 0.008 | 0 | 0 | 0.004 | -1.314 | -0.192 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0 | 0 | 0 | 1.609 | 1.6 | 1.3 | 0.9 | 0.6 |
| Operating Expenses
| 10.303 | 4.614 | 5.245 | 5.224 | 6.418 | 5.655 | 5.614 | 4.878 | 4.754 | 4.061 | 4.263 | 4.285 | 3.935 | 4.362 | 4.039 | 5.418 | 5.584 | 4.103 | 2.347 | 2.223 | 9.444 | 10.006 | 9.196 | 11.632 | 13.3 | 12 | 8.8 | 6 |
| Operating Income
| -9.503 | -4.898 | -4.185 | -4.586 | -5.806 | -4.477 | -4.647 | -3.736 | -3.565 | -3.338 | -3.327 | -3.464 | -3.29 | -3.399 | -3.197 | -4.966 | -5.147 | -4.058 | -2.419 | -2.382 | -1.014 | -1.504 | -0.491 | -3.404 | -0.9 | -0.7 | 1.4 | 0.9 |
| Operating Income Ratio
| -4.805 | -2.832 | -2.09 | -3.757 | -3.207 | -1.822 | -2.074 | -1.89 | -1.983 | -2.428 | -2.213 | -2.797 | -3.331 | -2.536 | -2.568 | -5.827 | -7.969 | -19.298 | -22.924 | -5.773 | -0.044 | -0.066 | -0.022 | -0.175 | -0.031 | -0.027 | 0.063 | 0.058 |
| Total Other Income Expenses Net
| -19.811 | -11.178 | -15.968 | -11.42 | -6.073 | -5.222 | -6.069 | 1.029 | -3.85 | -1.274 | -0.757 | 0.011 | 0.294 | 0.247 | 0.005 | 0.058 | 2.315 | 0.9 | 3.622 | -0.301 | -2.372 | -0.206 | -0.38 | -3.058 | -0.414 | -4.297 | 0.3 | -0.1 |
| Income Before Tax
| -29.314 | -16.077 | -20.153 | -16.006 | -11.878 | -9.699 | -10.716 | -2.707 | -7.415 | -4.613 | -4.084 | -3.452 | -2.996 | -3.152 | -3.192 | -4.908 | -2.832 | -3.158 | 1.203 | -2.683 | -1.286 | -1.71 | -0.871 | -6.462 | -1.3 | -5 | 1.7 | 0.8 |
| Income Before Tax Ratio
| -14.822 | -9.296 | -10.065 | -13.113 | -6.563 | -3.946 | -4.783 | -1.37 | -4.125 | -3.355 | -2.717 | -2.788 | -3.034 | -2.352 | -2.564 | -5.759 | -4.385 | -15.02 | 11.399 | -6.503 | -0.055 | -0.075 | -0.04 | -0.332 | -0.044 | -0.192 | 0.076 | 0.052 |
| Income Tax Expense
| 0 | 0.748 | 14.45 | 8.344 | -0.217 | -1.054 | 5.863 | 4.5 | 4.146 | 1.303 | 0.757 | -0.002 | 0.137 | -0.024 | -0.623 | 0 | -0.52 | -0.745 | 0.33 | -0.941 | 0.003 | 0.003 | 0.016 | 1.152 | -0.5 | -0.6 | 0.7 | 0.3 |
| Net Income
| -29.314 | -16.824 | -34.604 | -24.35 | -11.661 | -9.699 | -10.716 | -2.707 | -7.415 | -4.613 | -4.084 | -3.45 | -2.996 | -3.128 | -2.568 | -4.908 | -1.156 | -2.413 | 0.873 | 12.713 | -1.289 | -1.488 | 3.448 | -8.001 | -0.8 | -4.4 | 1 | 0.5 |
| Net Income Ratio
| -14.822 | -9.729 | -17.281 | -19.949 | -6.443 | -3.946 | -4.783 | -1.37 | -4.125 | -3.355 | -2.717 | -2.786 | -3.034 | -2.334 | -2.063 | -5.759 | -1.789 | -11.475 | 8.273 | 30.81 | -0.055 | -0.065 | 0.158 | -0.411 | -0.027 | -0.169 | 0.045 | 0.032 |
| EPS
| -1.509 | -1.61 | -3.418 | -5.322 | -7.984 | -15.332 | -9.617 | -3 | -10.8 | -13.2 | -13.2 | -12.9 | -23.1 | -40.5 | -42.6 | -67.2 | -33.3 | -30.3 | 8.7 | -7.5 | -5.68 | -6.7 | 16.8 | -43.8 | -5.14 | -28.36 | 6.9 | 5.1 |
| EPS Diluted
| -1.509 | -1.61 | -3.418 | -5.322 | -7.984 | -15.332 | -9.617 | -3 | -10.8 | -13.2 | -13.2 | -12.9 | -23.1 | -40.5 | -42.6 | -67.2 | -33.3 | -30.3 | 8.4 | -7.5 | -5.68 | -6.7 | 16.8 | -43.8 | -5.14 | -28.36 | 6.3 | 4.2 |
| EBITDA
| -9.391 | -5.405 | -5.528 | -7.457 | -6.413 | -5.437 | -4.652 | -3.718 | -3.244 | -3.244 | -3.665 | -3.356 | -2.718 | -2.955 | -2.987 | -4.708 | -5.147 | -3.912 | -2.419 | -2.246 | -1.194 | -0.202 | 0.925 | -1.795 | -0.112 | 0.344 | 2.3 | 1.5 |
| EBITDA Ratio
| -4.748 | -3.125 | -2.761 | -6.11 | -3.543 | -2.212 | -2.076 | -1.881 | -1.804 | -2.359 | -2.438 | -2.71 | -2.752 | -2.205 | -2.4 | -5.525 | -7.969 | -18.602 | -22.924 | -5.443 | -0.051 | -0.009 | 0.042 | -0.092 | -0.004 | 0.013 | 0.103 | 0.097 |